• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients.

作者信息

Haller Maria C, Kaiser Robert A, Langthaler Simon, Brandstetter Clara, Apfalter Petra, Kerschner Heidrun, Cejka Daniel

机构信息

Internal Medicine III-Nephrology, Transplantation Medicine, Rheumatology, Ordensklinikum, Linz, Austria.

Section for Clinical Biometrics, Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria.

出版信息

Transpl Int. 2022 Jan 4;35:10026. doi: 10.3389/ti.2021.10026. eCollection 2021.

DOI:10.3389/ti.2021.10026
PMID:35185359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8842265/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1485/8842265/3147715d2069/ti-35-10026-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1485/8842265/3147715d2069/ti-35-10026-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1485/8842265/3147715d2069/ti-35-10026-g001.jpg

相似文献

1
Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients.肾移植受者中mRNA-1273和BNT162b2新冠病毒mRNA疫苗免疫原性的比较
Transpl Int. 2022 Jan 4;35:10026. doi: 10.3389/ti.2021.10026. eCollection 2021.
2
Safety and efficacy of one and two booster doses of SARS-CoV-2 mRNA vaccines in kidney transplant recipients: A randomized clinical trial.肾移植受者单次和两次加强接种 SARS-CoV-2 mRNA 疫苗的安全性和有效性：一项随机临床试验。
Transpl Infect Dis. 2023 Oct;25(5):e14150. doi: 10.1111/tid.14150. Epub 2023 Sep 19.
3
Efficacy and safety of mRNA SARS-CoV-2 vaccines in lung transplant recipients.mRNA SARS-CoV-2 疫苗在肺移植受者中的疗效和安全性。
J Infect Chemother. 2022 Aug;28(8):1153-1158. doi: 10.1016/j.jiac.2022.04.019. Epub 2022 May 17.
4
Seroprevalence of SARS-CoV-2 spike IgG antibodies after the second BNT162b2 mRNA vaccine in Japanese kidney transplant recipients.日本肾移植受者接种第二剂 BNT162b2 mRNA 疫苗后对 SARS-CoV-2 刺突 IgG 抗体的血清阳性率。
Sci Rep. 2022 Apr 7;12(1):5876. doi: 10.1038/s41598-022-09897-0.
5
Differences in Antibody Responses Between an Inactivated SARS-CoV-2 Vaccine and the BNT162b2 mRNA Vaccine in Solid-Organ Transplant Recipients.实体器官移植受者中灭活 SARS-CoV-2 疫苗和 BNT162b2 mRNA 疫苗的抗体反应差异。
Exp Clin Transplant. 2021 Dec;19(12):1334-1340. doi: 10.6002/ect.2021.0402.
6
Differences in IgG Antibody Responses following BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines.BNT162b2 和 mRNA-1273 两种 SARS-CoV-2 疫苗接种后的 IgG 抗体反应差异。
Microbiol Spectr. 2021 Dec 22;9(3):e0116221. doi: 10.1128/Spectrum.01162-21. Epub 2021 Nov 10.
7
Humoral immune response after different SARS-CoV-2 vaccination regimens.不同 SARS-CoV-2 疫苗接种方案后的体液免疫应答。
BMC Med. 2022 Jan 21;20(1):31. doi: 10.1186/s12916-021-02231-x.
8
The SARS-CoV-2-neutralizing capacity of kidney transplant recipients 4 weeks after receiving a second dose of the BNT162b2 vaccine.肾移植受者在接种第二剂BNT162b2疫苗4周后的新冠病毒中和能力。
Kidney Int. 2021 Nov;100(5):1129-1131. doi: 10.1016/j.kint.2021.09.006. Epub 2021 Sep 20.
9
Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic.在大流行期间，mRNA SARS-CoV-2 疫苗反应不足和肾移植受者 COVID-19 重症发生率高。
Am J Transplant. 2022 Mar;22(3):801-812. doi: 10.1111/ajt.16902. Epub 2021 Dec 10.
10
Immunogenicity and Adverse Effects of the 2-Dose BNT162b2 Messenger RNA Vaccine Among Liver Transplantation Recipients.肝移植受者中 2 剂 BNT162b2 mRNA 疫苗的免疫原性和不良反应。
Liver Transpl. 2022 Feb;28(2):215-223. doi: 10.1002/lt.26366. Epub 2021 Dec 8.

引用本文的文献

1
Successful SARS-CoV-2 mRNA Vaccination Program in Allogeneic Hematopoietic Stem Cell Transplant Recipients-A Retrospective Single-Center Analysis.异基因造血干细胞移植受者中成功的新型冠状病毒2型信使核糖核酸疫苗接种计划——一项回顾性单中心分析
Vaccines (Basel). 2023 Sep 28;11(10):1534. doi: 10.3390/vaccines11101534.
2
[Update of the recommendations on the management of the SARS-CoV-2 coronavirus pandemic (COVID-19) in kidney transplant patients.].[肾移植患者中严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）冠状病毒大流行（COVID-19）管理建议的更新。]
Nefrologia. 2022 Nov 15. doi: 10.1016/j.nefro.2022.11.001.
3
Humoral and Cellular Immunogenicity of Six Different Vaccines against SARS-CoV-2 in Adults: A Comparative Study in Tunisia (North Africa).

本文引用的文献

1
Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine.肾移植患者与透析患者对SARS-CoV-2疫苗的体液免疫和细胞免疫：一项使用mRNA-1273或BNT162b2 mRNA疫苗的前瞻性多中心观察性研究。
Lancet Reg Health Eur. 2021 Oct;9:100178. doi: 10.1016/j.lanepe.2021.100178. Epub 2021 Jul 23.
2
Occurrence of severe COVID-19 in vaccinated transplant patients.接种疫苗的移植患者中出现重症 COVID-19 情况。
Kidney Int. 2021 Aug;100(2):477-479. doi: 10.1016/j.kint.2021.05.011. Epub 2021 May 23.
3
六种不同的抗SARS-CoV-2成人疫苗的体液和细胞免疫原性：突尼斯（北非）的一项比较研究
Vaccines (Basel). 2022 Jul 27;10(8):1189. doi: 10.3390/vaccines10081189.
4
Long-Term Humoral Response After a Second Dose of SARS-CoV-2 mRNA Vaccine in Japanese Kidney Transplant Recipients.日本肾移植受者接种第二剂SARS-CoV-2 mRNA疫苗后的长期体液免疫反应
Front Microbiol. 2022 Jun 9;13:922042. doi: 10.3389/fmicb.2022.922042. eCollection 2022.
Clinically Significant COVID-19 Following SARS-CoV-2 Vaccination in Kidney Transplant Recipients.
肾移植受者接种SARS-CoV-2疫苗后出现具有临床意义的COVID-19。
Am J Kidney Dis. 2021 Aug;78(2):314-317. doi: 10.1053/j.ajkd.2021.05.004. Epub 2021 May 18.
4
Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus.肾移植受者在未接触过病毒的情况下，对 mRNA SARS-CoV-2 BNT162b2 疫苗的体液反应降低。
Am J Transplant. 2021 Aug;21(8):2719-2726. doi: 10.1111/ajt.16615. Epub 2021 May 7.
5
Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers.五种市售血清学检测方法检测 SARS-CoV-2 抗体的性能比较及识别高中和抗体滴度个体。
J Clin Microbiol. 2021 Jan 21;59(2). doi: 10.1128/JCM.02257-20.
6
Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe.欧洲透析患者和肾移植受者的 ERA-EDTA 注册中心研究结果表明，他们因 COVID-19 导致的死亡率很高。
Kidney Int. 2020 Dec;98(6):1540-1548. doi: 10.1016/j.kint.2020.09.006. Epub 2020 Oct 15.
7
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison.五种 SARS-CoV-2 免疫测定法的性能特征：头对头基准比较。
Lancet Infect Dis. 2020 Dec;20(12):1390-1400. doi: 10.1016/S1473-3099(20)30634-4. Epub 2020 Sep 23.